Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Vantictumab | 1345009-45-1 | Details |
| Vc-seco-DUBA | C65H75ClN12O17 | 1345681-58-4 | Details |
| MPT0B392 | C19H20N2O6S | 1346169-92-3 | Details |
| Enfortumab vedotin-ejfv | 1346452-25-2 | Details |
| DHODH-IN-23 | C24H21ClFNO4 | 1346705-53-0 | Details |
| NSC639828 | C18H13BrClN5O3 | 134742-26-0 | Details |
| Guselkumab | 1350289-85-8 | Details |
| Margetuximab | 1350624-75-7 | Details |
| ONC1-13B | C22H16F4N4O3S | 1351185-54-0 | Details |
| Obiltoxaximab | 1351337-07-9 | Details |
| Pritoxaximab | 1351470-16-0 | Details |
| Setoxaximab | 1351470-17-1 | Details |
| GSK299423 | C25H27N5O2S | 1352149-24-6 | Details |
| EW-7195 | C23H18N8 | 1352609-28-9 | Details |
| TG-2-IN-1 | C8H13ClN2OS | 135273-74-4 | Details |
| MIV-247 | C17H24F3N3O4 | 1352817-76-5 | Details |
| (2RS)-FPMPA | C9H13FN5O4P | 135295-27-1 | Details |
| Trazpiroben | C31H39N3O4 | 1352993-39-5 | Details |
| Enoblituzumab | 1353485-38-7 | Details |
| γ-Secretase modulator 13 | C22H23FN6S | 1353570-40-7 | Details |
| UNC0006 | C24H29Cl2N3O2 | 1354030-14-0 | Details |
| UNC9975 | C23H28Cl2N4O2 | 1354030-19-5 | Details |
| UNC9995 | C20H21Cl2N3OS | 1354030-52-6 | Details |
| FL118 | C21H16N2O6 | 135415-73-5 | Details |
| Lodelcizumab | 1355338-54-3 | Details |
| OTS447 | C27H32ClN3O2 | 1356943-67-3 | Details |
| Fletikumab | 1357158-22-5 | Details |
| (4R)-RO5263397 | C10H11FN2O | 1357266-80-8 | Details |
| UBE2T/FANCL-IN-1 | C19H31N7 | 1359415-02-3 | Details |
| Fosopamine(HCl) | C9H14NO5P.ClH | 135962-35-5 | Details |
| RTC13 | C14H9N3O4S | 1359825-94-7 | Details |
| Tarextumab | 1359940-55-8 | Details |
| PI3K-IN-31 | C19H23F2N7O3 | 1359956-12-9 | Details |
| Nexopamil | C24H40N2O3 | 136033-49-3 | Details |
| M3541 | C23H17FN6O2 | 1360628-91-6 | Details |
| Antioxidant agent-1 | C15H12O3 | 136068-43-4 | Details |
| DSPE-Mal | C48H87N2O11P | 1360858-99-6 | Details |
| AMG-1694 | C23H30F3N3O4S2 | 1361217-07-3 | Details |
| ACT-462206 | C20H24N2O4S | 1361321-96-1 | Details |
| Fluorizoline | C15H8Cl2F3NS | 1362243-70-6 | Details |
| Idarucizumab | 1362509-93-0 | Details |
| Codrituzumab | 1365267-33-9 | Details |
| Emibetuzumab | 1365287-97-3 | Details |
| KP-457 | C21H24N2O7S2 | 1365803-52-6 | Details |
| NS-102 | C12H11N3O4 | 136623-01-3 | Details |
| Mopidamol | C19H31N7O4 | 13665-88-8 | Details |
| Atevirdine | C21H25N5O2 | 136816-75-6 | Details |
| Sophoraflavanone H | C34H30O9 | 136997-68-7 | Details |
| CUR5g | C22H20N2O2 | 1370032-20-4 | Details |
| Anatumomab mafenatox | 1370261-50-9 | Details |
| P505-15 Acetate | C21H27N9O3 | 1370261-98-5 | Details |
| Nisin Z | C141H229N41O38S7 | 137061-46-2 | Details |
| Cassiaside | C20H20O10 | 13709-03-0 | Details |
| Turosteride | C27H45N3O3 | 137099-09-3 | Details |
| Aptiganel | C20H21N3 | 137159-92-3 | Details |
| Iliparcil | C16H18O6S | 137214-72-3 | Details |
| THX-B | C16H24N6O4 | 1372206-64-8 | Details |
| Osemozotan HCl | C19H22ClNO5 | 137275-80-0 | Details |
| Tosatoxumab | 1374419-41-6 | Details |
| SCFSkp2-IN-2 | C17H20N4O2 | 1375060-02-8 | Details |
| Kukoamine B mesylate | C28H42N4O6.CH4O3S | 1375179-86-4 | Details |
| Anetumab ravtansine | 1375258-01-7 | Details |
| Ulocuplumab | 1375830-34-4 | Details |
| LY3020371 hydrochloride | C15 H15 F2 N O5 S . Cl H | 1377615-44-5 | Details |
| ERD03 | C21H25NO3 | 1377897-01-2 | Details |
| Spiroglumide | 137795-35-8 | Details |
| Zifaxaban | C20H16ClN3O4S | 1378266-98-8 | Details |
| CGP-20712 | C23H25F3N4O5 | 137888-49-4 | Details |
| CPI-0610 carboxylic acid | C20H15ClN2O3 | 1380089-81-5 | Details |
| GAL-021 sulfate | C11H24N6O5S | 1380342-00-6 | Details |
| Kv3 modulator 1 | C20H20N4O4 | 1380696-64-9 | Details |
| D-Glucose-1,2-13C2 | C6H12O6 | 138079-87-5 | Details |
| TBK1/IKKε-IN-4 | C28H35N7O4 | 1381930-17-1 | Details |
| DpC | C19H23N5S | 1382469-39-7 | Details |
| MpsBAY2a | C29H28N6O | 1382477-96-4 | Details |
| 2,3-Bis(3-indolylmethyl)indole | 138250-72-3 | Details |
| PI3K-IN-38 | C20H24N6O2 | 1382979-64-7 | Details |
| IHVR-11029 | C18H27F2NO5 | 1383152-30-4 | Details |
| DSPE-NHS | C49H89N2O13P | 1383932-86-2 | Details |
| Diphlorethohydroxycarmalol | C24H16O13 | 138529-04-1 | Details |
| Nolomirole HCl | C19H28ClNO4 | 138531-51-8 | Details |
| ADR-851 free base | C14H18ClN3O2 | 138559-56-5 | Details |
| Sevirumab | 138660-96-5 | Details |
| Tuvirumab | 138660-97-6 | Details |
| Nebacumab | 138661-01-5 | Details |
| Furnidipine | C21H24N2O7 | 138661-03-7 | Details |
| 1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl- | C23H20N2S | 138801-72-6 | Details |
| NorA-IN-1 | C18H18O5 | 1389310-69-3 | Details |
| ME1111 | C12H14N2O | 1391758-52-3 | Details |
| Varlilumab | 1393344-72-3 | Details |
| Temelimab | 1393641-34-3 | Details |
| Diridavumab | 1393659-46-5 | Details |
| CP 96021 | C29H21FN4OS | 139401-43-7 | Details |
| 8alpha-Hydroxyhirsutinolide | C15H20O6 | 1394156-45-6 | Details |
| (+)-Picumeterol | C21H29Cl2N3O2 | 139423-79-3 | Details |
| Golgicide A-1 | C17H14F2N2 | 1394285-49-4 | Details |
| Golgicide A-2 | C17H14F2N2 | 1394285-50-7 | Details |
| LPA1 receptor antagonist 1 | C28H26N4O4 | 1396006-71-5 | Details |
| Sigma-LIGAND-1 hydrochloride | C27H34ClNO4 | 139652-86-1 | Details |
| Anti-amyloid agent-1 | C21H17F3N2O3 | 1396778-73-6 | Details |
| Product Total： Product Page： | ||||
| 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||